Evidence map›Paper›PMID 36072388›Full record

ArticleFrontiers in veterinary science2022

Gholamreza Mesbah, Fatemeh Namazi, Fatemeh T Shamsabadi, Zahra Maleki, Mehrab Nasirikenari, Majid Shahbazi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in veterinary science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Tumour induction in BALB/c mice for imaging studies: An improved protocol.Journal of cellular and molecular medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Gholamreza MesbahDepartment of Pathobiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Fatemeh NamaziDepartment of Pathobiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Fatemeh T ShamsabadiMedical Cellular and Molecular Research Center, Golestan University of Medical Sciences and Health Services, Gorgan, Iran.
Zahra MalekiMedical Cellular and Molecular Research Center, Golestan University of Medical Sciences and Health Services, Gorgan, Iran.
Mehrab NasirikenariDepartment of Molecular Biology, North Research Center of Pasteur Institute of Iran, Amol, Iran.
Majid ShahbaziMedical Cellular and Molecular Research Center, Golestan University of Medical Sciences and Health Services, Gorgan, Iran.
Golestan University · IRShiraz University · IRPasteur Institute of Iran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysregulation of G1 cyclins (cyclins D1 A and E) expression contributes to the loss of standard cell cycle control during tumorigenesis. This study aims to evaluate the inhibitory effect of G1 cyclins in nude mice. The human breast cancer MDA-MB-231 cells were subcutaneously transplanted into the supra-femoral right side of female Balb/c-nude mice. The dual shRNA vector harboring G1 cyclins shRNAs (bipSUR) was intratumorally injected by the

Indexed as

breast cancercyclin D1cyclin Edual shRNA vectorG1 cyclinsgene therapyMDA-MB-231 xenograft modelnude mice

Identifiers

PMID36072388
PMCPMC9443516
OpenAlexW4292649392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.